ZypAdhera ® (olanzapine pamoate monohydrate)

This information is intended for UK registered healthcare professionals only as a scientific exchange in response to your search for information. Please refer to the link for full prescribing information: ZypAdhera Summary of Product Characteristics (SmPC)

ZypAdhera® (olanzapine pamoate): Gluten

The solvent contains pharmaceutical grade highly purified mannitol that is obtained from either corn or wheat starch.

Further Label Information

The active ingredient of ZypAdhera is olanzapine pamoate.1

The excipients are:1

Powder:

  • None

Solvent

  • Carmellose sodium

  • Mannitol

  • Polysorbate 80

  • Water for injections

  • Hydrochloric acid (for pH adjustment)

  • Sodium hydroxide (for pH adjustment)

ZypAdhera is contraindicated in patients with hypersensitivity to the active substance or to any of the excipients of ZypAdhera.1

References

1. ZypAdhera [summary of product characteristics] Eli Lilly Netherland B.V., The Netherlands.

Date of Last Review: February 13, 2020

Contact Lilly

Call or Email us

If you want to ask a Medical Information question or you want to report an adverse event or product complaint you can call us or email us at ukmedinfo@lilly.com

Available Mon - Fri, 8am - 4pm, excluding Bank Holidays

Or you can

Ask us a question Chat with Us If you have a question, you can chat online with a Lilly Medical Information professional.

Submit a question